IQVIA - IQV Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $256.81
Forecasted Upside: 36.35%
Number of Analysts: 15
Breakdown:
0 Sell Ratings
2 Hold Ratings
13 Buy Ratings
0 Strong Buy Ratings

^$188.35 As of 03/24/2023 01:00 AM ET

▲ +0.35 (0.19%)

1 month | 3 months | 12 months

Get New IQVIA Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for IQV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IQV

^$256.81

▲ +36.35% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for IQVIA in the last 3 months. The average price target is $256.81, with a high forecast of $275.00 and a low forecast of $235.00. The average price target represents a 36.35% upside from the last price of $188.35.

Current Consensus is Buy

The current consensus among 15 contributing investment analysts is to buy stock in IQVIA. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

10/2/2021

0 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/31/2021

0 strong buy ratings
16 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/31/2022

0 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/29/2022

0 strong buy ratings
14 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

9/27/2022

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/26/2022

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/24/2023

0 strong buy ratings
13 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/26/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/17/2023	Truist Financial	Initiated Coverage	Buy	$265.00	Low
2/27/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$257.00 ➝ $263.00	Low
2/13/2023	Credit Suisse Group	Reiterated Rating	Outperform	$265.00	Low
2/13/2023	Morgan Stanley	Boost Target	Overweight	$240.00 ➝ $260.00	Low
1/27/2023	SVB Leerink	Reiterated Rating	Outperform		Low
1/13/2023	Robert W. Baird	Lower Target	Outperform	$266.00 ➝ $260.00	Low
12/6/2022	Cowen	Initiated Coverage	Outperform	$251.00	Low
12/6/2022	Cowen	Initiated Coverage	Outperform		Low
11/17/2022	Citigroup	Downgrade	Buy ➝ Neutral	$275.00 ➝ $245.00	Low
11/10/2022	Mizuho	Lower Target	Buy	$270.00 ➝ $250.00	Low
10/27/2022	Guggenheim	Boost Target		$249.00	Low
10/27/2022	Robert W. Baird	Boost Target		$266.00	Low
10/27/2022	Morgan Stanley	Lower Target	Overweight	$260.00 ➝ $240.00	Low
10/27/2022	Credit Suisse Group	Lower Target	Outperform	$300.00 ➝ $265.00	Low
10/27/2022	Citigroup	Lower Target	Buy	$290.00 ➝ $275.00	N/A
10/27/2022	Barclays	Boost Target	Overweight	$215.00 ➝ $235.00	N/A
10/18/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$290.00 ➝ $270.00	Low
10/10/2022	Guggenheim	Lower Target	Buy	$246.00 ➝ $234.00	Low
10/6/2022	Barclays	Lower Target	Overweight	$235.00 ➝ $215.00	Low
9/12/2022	Barclays	Lower Target	Overweight	$255.00 ➝ $235.00	Low
8/24/2022	Credit Suisse Group	Initiated Coverage	Outperform	$300.00	Low
8/18/2022	Argus	Boost Target		$260.00 ➝ $275.00	Low
7/22/2022	Guggenheim	Boost Target		$246.00	Low
7/22/2022	Morgan Stanley	Boost Target	Overweight	$255.00 ➝ $260.00	Low
7/22/2022	Evercore ISI	Boost Target		$265.00 ➝ $275.00	Low
7/22/2022	Robert W. Baird	Boost Target		$260.00 ➝ $265.00	Low
7/15/2022	SVB Leerink	Initiated Coverage	Outperform	$256.00	Low
7/13/2022	Barclays	Lower Target	Overweight	$240.00 ➝ $236.00	N/A
5/23/2022	Guggenheim	Initiated Coverage	Buy	$244.00	Low
4/28/2022	Piper Sandler	Upgrade	Neutral ➝ Overweight	$231.00 ➝ $255.00	Low
4/28/2022	Barclays	Lower Target		$275.00 ➝ $240.00	High
4/25/2022	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$290.00 ➝ $235.00	High
4/12/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$250.00 ➝ $290.00	Medium
3/23/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$255.00 ➝ $250.00	High
3/7/2022	Mizuho	Lower Target	Buy	$300.00 ➝ $270.00	High
2/17/2022	Piper Sandler	Lower Target	Neutral	$261.00 ➝ $231.00	Low
2/17/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$282.00 ➝ $255.00	Medium
2/16/2022	William Blair	Reiterated Rating	Outperform		Medium
2/16/2022	Morgan Stanley	Lower Target	Overweight	$290.00 ➝ $280.00	Medium
2/16/2022	UBS Group	Lower Target		$310.00 ➝ $290.00	Medium
12/20/2021	Mizuho	Boost Target	Buy	$290.00 ➝ $300.00	Low
11/18/2021	Piper Sandler	Boost Target	Neutral	$250.00 ➝ $261.00	Medium
11/18/2021	Mizuho	Boost Target	Buy	$282.00 ➝ $290.00	Low
11/17/2021	Jefferies Financial Group	Boost Target	Buy	$300.00 ➝ $309.00	Medium
11/17/2021	Citigroup	Boost Target	Buy	$300.00 ➝ $320.00	Medium
11/17/2021	KeyCorp	Boost Target	Overweight	$270.00 ➝ $290.00	Medium
11/17/2021	UBS Group	Boost Target	Positive ➝ Buy	$298.00 ➝ $310.00	Medium
11/12/2021	Evercore ISI	Reiterated Rating	Outperform		Medium
10/28/2021	Mizuho	Boost Target	Buy	$270.00 ➝ $282.00	Low
10/27/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$250.00 ➝ $282.00	Low
10/25/2021	Barclays	Boost Target	Overweight	$285.00 ➝ $287.00	Low
10/22/2021	Stifel Nicolaus	Boost Target	Buy	$300.00 ➝ $304.00	Low
10/22/2021	Morgan Stanley	Boost Target	Overweight	$280.00 ➝ $290.00	Medium
10/22/2021	Citigroup	Boost Target	Buy	$280.00 ➝ $300.00	Medium
10/15/2021	KeyCorp	Boost Target	Overweight	$260.00 ➝ $270.00	Low
9/10/2021	Argus	Boost Target	Buy	$260.00 ➝ $290.00	Low
7/28/2021	Morgan Stanley	Boost Target	Overweight	$260.00 ➝ $280.00	Medium
7/28/2021	Mizuho	Boost Target	Buy	$250.00 ➝ $270.00	Low
7/28/2021	Piper Sandler	Boost Target	Neutral	$204.00 ➝ $235.00	Medium
7/28/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$244.00 ➝ $250.00	Medium
7/28/2021	Citigroup	Boost Target	Buy	$265.00 ➝ $280.00	Medium
7/28/2021	Robert W. Baird	Boost Target	Outperform	$273.00 ➝ $285.00	Medium
7/20/2021	Credit Suisse Group	Boost Target	Outperform	$242.00 ➝ $265.00	High
7/13/2021	Barclays	Boost Target	Overweight	$260.00 ➝ $285.00	Low
5/14/2021	KeyCorp	Boost Target	Overweight	$255.00 ➝ $260.00	Medium
5/12/2021	Argus	Boost Target	Buy	$220.00 ➝ $260.00	Low
4/26/2021	Truist Financial	Boost Target	Buy	$235.00 ➝ $260.00	Low
4/26/2021	Morgan Stanley	Boost Target	Overweight	$220.00 ➝ $260.00	Low
4/26/2021	Barclays	Boost Target	Overweight	$235.00 ➝ $260.00	Low
4/23/2021	Citigroup	Boost Target		$225.00 ➝ $265.00	Low
4/23/2021	Jefferies Financial Group	Boost Target	Buy	$259.00 ➝ $273.00	Low
4/23/2021	Robert W. Baird	Boost Target	Outperform	$238.00 ➝ $250.00	Medium
4/23/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$200.00 ➝ $244.00	Medium
4/23/2021	Mizuho	Boost Target	Buy	$218.00 ➝ $250.00	Medium
4/16/2021	Stephens	Upgrade	Equal Weight ➝ Overweight	$180.00 ➝ $250.00	Medium
4/9/2021	Mizuho	Boost Target	Buy	$210.00 ➝ $218.00	Medium
3/15/2021	KeyCorp	Upgrade	Sector Weight ➝ Overweight	$218.00	High
3/8/2021	Barclays	Initiated Coverage	Overweight	$220.00	N/A
3/2/2021	Barclays	Initiated Coverage	Overweight	$220.00	Low
2/11/2021	Truist Financial	Boost Target		$197.00 ➝ $235.00	Low
2/11/2021	Wells Fargo & Company	Boost Target	Overweight	$205.00 ➝ $230.00	Low
2/11/2021	Robert W. Baird	Boost Target	Outperform	$208.00 ➝ $221.00	Low
2/11/2021	Morgan Stanley	Boost Target	Overweight	$205.00 ➝ $220.00	Low
2/11/2021	Mizuho	Boost Target	Buy	$200.00 ➝ $210.00	Low
2/11/2021	Piper Sandler	Boost Target	Neutral	$179.00 ➝ $204.00	Low
12/18/2020	Mizuho	Boost Target	Buy	$190.00 ➝ $200.00	Medium
10/22/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$180.00 ➝ $196.00	Low
10/21/2020	UBS Group	Boost Target	Buy	$204.00 ➝ $224.00	Medium
10/21/2020	Morgan Stanley	Boost Target	Overweight	$182.00 ➝ $195.00	Medium
10/21/2020	Piper Sandler	Boost Target	Neutral	$140.00 ➝ $179.00	Medium
10/21/2020	Mizuho	Boost Target	Buy	$180.00 ➝ $190.00	Medium
7/23/2020	Robert W. Baird	Boost Target	Outperform	$156.00 ➝ $180.00	High
7/23/2020	Morgan Stanley	Boost Target	Overweight	$158.00 ➝ $182.00	High
7/23/2020	Wells Fargo & Company	Boost Target	Overweight	$155.00 ➝ $185.00	High
7/23/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$145.00 ➝ $180.00	High
7/23/2020	Mizuho	Boost Target	Buy	$153.00 ➝ $180.00	High
7/23/2020	Citigroup	Boost Target	Buy	$160.00 ➝ $200.00	High
7/7/2020	Bank of America	Boost Target	Buy	$145.00 ➝ $156.00	Medium
7/6/2020	Stephens	Initiated Coverage	Equal Weight	$150.00	Low
4/29/2020	SunTrust Banks	Boost Target	Buy	$128.00 ➝ $172.00	Medium
4/29/2020	Piper Sandler	Boost Target		$115.00 ➝ $138.00	High
4/29/2020	Stifel Nicolaus	Boost Target	Buy	$159.00 ➝ $165.00	High
4/29/2020	Wells Fargo & Company	Boost Target	Overweight	$140.00 ➝ $150.00	High
4/29/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$150.00 ➝ $145.00	High
4/29/2020	Citigroup	Boost Target	Top Pick ➝ Buy	$155.00 ➝ $160.00	High
4/28/2020	UBS Group	Lower Target	Buy	$200.00 ➝ $162.00	High
4/9/2020	Citigroup	Lower Target	Buy	$195.00 ➝ $155.00	Low
4/8/2020	Piper Sandler	Lower Target		$163.00 ➝ $115.00	High
4/6/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$190.00 ➝ $150.00	High
4/3/2020	Mizuho	Lower Target	Buy	$153.00 ➝ $120.00	Medium
4/2/2020	Credit Suisse Group	Lower Target	Outperform	$175.00 ➝ $157.00	Low
3/31/2020	Stifel Nicolaus	Lower Target	Buy	$194.00 ➝ $159.00	Low
3/30/2020	Wells Fargo & Company	Lower Target	Overweight	$190.00 ➝ $140.00	Low
3/27/2020	Morgan Stanley	Lower Target	Overweight	$170.00 ➝ $158.00	High
3/26/2020	Barclays	Lower Target	Overweight	$192.00 ➝ $166.00	Low
3/24/2020	Cfra	Lower Target	Buy	$185.00 ➝ $110.00	Medium
3/23/2020	Jefferies Financial Group	Lower Target	Buy	$195.00 ➝ $127.00	High
3/17/2020	SunTrust Banks	Lower Target	Buy	$184.00 ➝ $128.00	Low
3/2/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$190.00	High
2/13/2020	Piper Sandler	Boost Target		$145.00 ➝ $163.00	Medium
2/13/2020	UBS Group	Boost Target	Buy	$187.00 ➝ $200.00	Low
2/13/2020	Robert W. Baird	Boost Target	Outperform	$172.00 ➝ $181.00	Low
2/13/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$180.00 ➝ $195.00	Low
2/13/2020	Citigroup	Boost Target	Buy	$185.00 ➝ $195.00	Low
2/12/2020	Stifel Nicolaus	Boost Target	Buy	$180.00 ➝ $194.00	Low
2/12/2020	Cfra	Upgrade	Hold ➝ Buy	$148.00 ➝ $185.00	Low
1/7/2020	Wells Fargo & Company	Initiated Coverage	Overweight	$180.00	Low
1/6/2020	Citigroup	Initiated Coverage	Buy	$185.00	Medium
12/20/2019	Credit Suisse Group	Reiterated Rating	Buy	$170.00	N/A
12/13/2019	Cfra	Upgrade	Sell ➝ Hold		Low
11/14/2019	Wolfe Research	Upgrade	Peer Perform ➝ Outperform		Low
7/25/2019	Credit Suisse Group	Boost Target	Outperform	$165.00 ➝ $170.00	Low
7/25/2019	Wells Fargo & Company	Boost Target	Outperform	$170.00 ➝ $178.00	Low
7/25/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$160.00 ➝ $180.00	Low
7/15/2019	Barclays	Set Target	Buy	$180.00	Medium
6/27/2019	SunTrust Banks	Boost Target	Buy	$155.00 ➝ $175.00	Low
6/21/2019	Mizuho	Upgrade	Neutral ➝ Buy	$150.00 ➝ $175.00	High
6/19/2019	Mizuho	Boost Target	Neutral ➝ Neutral	$145.00 ➝ $150.00	High
6/19/2019	Credit Suisse Group	Boost Target	Outperform	$159.00 ➝ $165.00	High
6/19/2019	Morgan Stanley	Boost Target	Overweight	$156.00 ➝ $170.00	High
6/19/2019	Stifel Nicolaus	Boost Target	Buy	$167.00 ➝ $178.00	High
6/19/2019	William Blair	Reiterated Rating	Outperform		High
5/28/2019	SVB Leerink	Initiated Coverage	Outperform ➝ Outperform	$160.00	Low
4/2/2019	Wolfe Research	Initiated Coverage	Market Perform		Low
3/18/2019	Barclays	Boost Target	Overweight ➝ Overweight	$160.00 ➝ $167.00	Low
2/25/2019	Argus	Boost Target	Buy ➝ Buy	$140.00 ➝ $160.00	Low
2/19/2019	Wells Fargo & Company	Boost Target	Outperform ➝ Outperform	$140.00 ➝ $160.00	Low
2/15/2019	Barclays	Reiterated Rating	Buy	$155.00	Low
2/15/2019	UBS Group	Set Target	Buy	$155.00 ➝ $170.00	Low
2/15/2019	Piper Jaffray Companies	Boost Target	Neutral	$148.00	Low
1/18/2019	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$136.00 ➝ $150.00	High
1/11/2019	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		Low
12/3/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$130.00 ➝ $145.00	High
10/23/2018	Royal Bank of Canada	Boost Target	Outperform	$137.00	Low
10/23/2018	Piper Jaffray Companies	Boost Target	Neutral	$131.00	High
10/23/2018	Barclays	Boost Target	Overweight ➝ Overweight	$130.00 ➝ $140.00	High
10/9/2018	UBS Group	Initiated Coverage	Buy ➝ Buy		Low
10/2/2018	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$143.00 ➝ $146.00	Low
8/31/2018	Raymond James	Boost Target	Strong-Buy ➝ Strong-Buy	$136.00 ➝ $145.00	Low
8/23/2018	Argus	Set Target	Buy	$136.00	Low
8/13/2018	Wells Fargo & Company	Boost Target	Outperform ➝ Outperform	$120.00 ➝ $140.00	Low
8/6/2018	Mizuho	Set Target	Hold	$120.00	Low
7/25/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$97.00	High
7/25/2018	SunTrust Banks	Boost Target	Buy	$140.00	High
7/25/2018	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$127.00 ➝ $143.00	High
7/25/2018	JPMorgan Chase & Co.	Boost Target	Overweight	$135.00	High
7/25/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$121.00 ➝ $130.00	High
7/25/2018	Barclays	Reiterated Rating	Overweight ➝ Overweight	$120.00 ➝ $130.00	High
7/25/2018	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$128.00 ➝ $150.00	High
7/25/2018	Royal Bank of Canada	Reiterated Rating	Buy	$129.00	High
7/25/2018	Bank of America	Upgrade	Neutral ➝ Buy	$135.00	High
7/20/2018	Jefferies Financial Group	Reiterated Rating	Hold	$119.00	Low
7/19/2018	Royal Bank of Canada	Reiterated Rating	$110.25	$128.00	Low
7/3/2018	Raymond James	Upgrade	Outperform ➝ Strong-Buy		Medium
6/18/2018	Robert W. Baird	Upgrade	Neutral ➝ Outperform		High
4/13/2018	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy		Medium
4/9/2018	Argus	Boost Target	Buy ➝ Buy	$110.00 ➝ $112.00	Low

(Data available from 3/26/2018 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

4 very positive mentions
20 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

8/28/2022

1 very positive mentions
13 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

9/27/2022

5 very positive mentions
18 positive mentions
5 negative mentions
2 very negative mentions

Mentions as of

10/27/2022

1 very positive mentions
26 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

11/26/2022

4 very positive mentions
6 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

12/26/2022

7 very positive mentions
6 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

1/25/2023

17 very positive mentions
24 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

2/24/2023

11 very positive mentions
14 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/26/2023

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Negative

No negative mentions tracked during this time.

Positive

marketbeat.com
3/23/2023
IQVIA Holdings Inc. (NYSE:IQV) Given Consensus Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com
3/21/2023
IQVIA (NYSE:IQV) Receives New Coverage from Analysts at Truist Financial
marketbeat.com
3/17/2023
Truist Financial Begins Coverage on IQVIA (NYSE:IQV)
americanbankingnews.com
3/16/2023
IQVIA (NYSE:IQV) Now Covered by Analysts at StockNews.com
finance.yahoo.com
3/13/2023
IQVIA Holdings (NYSE:IQV) sheds 10% this week, as yearly returns fall more in line with earnings growth

Very Positive

marketbeat.com
19 hours ago
Maryland State Retirement & Pension System Takes Position in IQVIA Holdings Inc. (NYSE:IQV)
marketbeat.com
3/22/2023
Howard Capital Management Group LLC Has $23.43 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)
marketbeat.com
3/21/2023
Ardevora Asset Management LLP Sells 241,839 Shares of IQVIA Holdings Inc. (NYSE:IQV)
marketbeat.com
3/19/2023
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by DNB Asset Management AS
marketbeat.com
3/17/2023
McGuire Investment Group LLC Has $15.25 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Today's Range

Now: $188.35

$183.15

$188.73

50 Day Range

MA: $216.29

$188.00

$240.65

52 Week Range

Now: $188.35

$165.75

$254.94

Volume

1,560,228 shs

Average Volume

1,203,996 shs

Market Capitalization

$35.06 billion

P/E Ratio

32.99

Dividend Yield

N/A

Beta

1.4

Frequently Asked Questions

What sell-side analysts currently cover shares of IQVIA?: The following Wall Street analysts have issued reports on IQVIA in the last twelve months: Argus, Barclays PLC, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Guggenheim, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, StockNews.com, SVB Leerink LLC, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for IQV.
What is the current price target for IQVIA?: 16 Wall Street analysts have set twelve-month price targets for IQVIA in the last year. Their average twelve-month price target is $256.81, suggesting a possible upside of 36.3%. Argus has the highest price target set, predicting IQV will reach $275.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $235.00 for IQVIA in the next year.
View the latest price targets for IQV.
What is the current consensus analyst rating for IQVIA?: IQVIA currently has 2 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IQV will outperform the market and that investors should add to their positions of IQVIA.
View the latest ratings for IQV.
What other companies compete with IQVIA?: Other companies that are similar to IQVIA include Marvell Technology, Waste Connections, Copart, Paychex and Fidelity National Information Services. Learn More about companies similar to IQVIA.
How do I contact IQVIA's investor relations team?: IQVIA's physical mailing address is 4820 EMPEROR BOULEVARD, DURHAM NC, 27703. The medical research company's listed phone number is (919) 998-2000 and its investor relations email address is [email protected] The official website for IQVIA is www.iqvia.com. Learn More about contacing IQVIA investor relations.

IQVIA - IQV Stock Price Target and Predictions

Analyst Price Target for IQV

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.65 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of IQVIA?

What is the current price target for IQVIA?

What is the current consensus analyst rating for IQVIA?

What other companies compete with IQVIA?

How do I contact IQVIA's investor relations team?